Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)

INTRODUCTION: The aim of the study was to assess the clinical efficacy, safety, and disease-modification effects of tramiprosate (homotaurine, ALZHEMED(TM)) in mild-to-moderate Alzheimer’s disease (AD). MATERIAL AND METHODS: Double-blind, placebo-controlled, randomized trial in 67 clinical centres a...

Descripción completa

Detalles Bibliográficos
Autores principales: Aisen, Paul S., Gauthier, Serge, Ferris, Steven H., Saumier, Daniel, Haine, Denis, Garceau, Denis, Duong, Anh, Suhy, Joyce, Oh, Joonmi, Lau, Wan C., Sampalis, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2011
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258678/
https://www.ncbi.nlm.nih.gov/pubmed/22291741
http://dx.doi.org/10.5114/aoms.2011.20612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258678/
https://www.ncbi.nlm.nih.gov/pubmed/22291741
http://dx.doi.org/10.5114/aoms.2011.20612

Ejemplares similares